risks of taking glp 1 GLP-1 medications linked to major drop in pancreatic, colorectal cancer risk https://www.medicalnewstoday.com/articles/weight-loss-drugs-glp-1-slash-risk -4-types-cancer-50-or-more-study GLP-1 Medications: Everything You Need

Moreover, efpeglenatide therapy reduced the risk of CV disease by about 27% compared to the placebo in the Effect of Efpeglenatide on Cardiovascular Outcomes (AMPLITUDE-O) study [51]

PubMed Central , For your reference: For your reference: For your reference: 22 Sofimajidpour, Heshmatollah, et al

Most patients notice improved sleep quality and faster recovery between sessions before they see any visible body composition change

Circular RNA ANAPC7 inhibits tumor growth and muscle wasting via PHLPP2-AKT-TGF- signaling axis in pancreatic cancer

Clinical studies show reductions in C-reactive protein, interleukin-6, and other inflammatory biomarkers